ABSTRACT
Aim This retrospective study was to evaluate whether an updated version of an attention binding computer therapy game based on the principle of Focal Ambient Visual Acuity Stimulation (FAVAS) would result in an optimized patient adherence of patching in 4- to 12-year-old patients with amblyopia.
Methods We analyzed anonymized electronically recorded data from patients treated with 2 different versions of attention binding computer therapy games regarding the gamefication aspect in 2015 and 2020. Depending on the treatment version, two groups of children treated with patching were compared. Patients in the Group 2015 used the old 1.0 version of therapy games, while Group 2020 used more attractive therapeutic games. Objective adherence was calculated by comparing the amount of minutes using the computer game as monitored in the automatized logbook versus prescribed minutes of using the game.
Results Children in the Group 2015 spent on average 2009.3±1372.1 (36 to 5472) minutes using FAVAS; children in the Group 2020 spent on average 2695.5±1526.8 (37.5 to 5672) minutes using the therapy. Meaning, Group 2020 spent 686.2 more minutes than Group 2015 (t=3.87, P<0.001). Although patient adherence was very variable, it significantly improved in the 2020 group up to 78% ± 46% compared to the 57% ± 34% in the Group 2015 (t=4.3, P<0.001).
Conclusion FAVAS 2020 with an improved gamefication aspect increased adherence significantly compared to the earlier version FAVAS 1.0, indicating that FAVAS could be an effective approach to support patching amblyopia treatment.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
DRKS00017633
Funding Statement
-
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee: Arztekammer des Saarlandes, Korperschaft des offentlichen Rechts, Ethikkommission. Ethical approval was given on 27.05.2019. Nr.118/19
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos